Interferon gamma responses to myelin peptides in multiple sclerosis correlate with a new clinical measure of disease progression (Q47635464)

4 February 2018

title

Interferon gamma responses to myelin peptides in multiple sclerosis correlate with a new clinical measure of disease progression (English)

1 reference

4 February 2018

0 references

Ioana R Moldovan

1

1 reference

4 February 2018

Richard A Rudick

2

1 reference

4 February 2018

Anne C Cotleur

3

1 reference

4 February 2018

Sarah E Born

4

1 reference

4 February 2018

Jar-Chi Lee

5

1 reference

4 February 2018

Matthew T Karafa

6

1 reference

4 February 2018

Clara M Pelfrey

7

1 reference

4 February 2018

publication date

1 August 2003

1 reference

4 February 2018

Journal of Neuroimmunology

published in

1 reference

4 February 2018

volume

141

1 reference

4 February 2018

issue

1-2

1 reference

4 February 2018

page(s)

132-140

1 reference

4 February 2018

T cells responsive to myelin basic protein in patients with multiple sclerosis

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900221-2

7 January 2021

Differential adhesion molecule requirements for immune surveillance and inflammatory recruitment

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900221-2

7 January 2021

Frequency of T cells specific for myelin basic protein and myelin proteolipid protein in blood and cerebrospinal fluid in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900221-2

7 January 2021

Interferon-gamma-secreting cells in multiple sclerosis patients treated with interferon beta-1b

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900221-2

7 January 2021

Repertoire dynamics of autoreactive T cells in multiple sclerosis patients and healthy subjects: epitope spreading versus clonal persistence.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900221-2

7 January 2021

Increased immunoreactivity to two overlapping peptides of myelin proteolipid protein in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900221-2

7 January 2021

T-cell reactivity to multiple myelin antigens in multiple sclerosis patients and healthy controls

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900221-2

7 January 2021

Longitudinal study of antimyelin T-cell reactivity in relapsing-remitting multiple sclerosis: association with clinical and MRI activity

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900221-2

7 January 2021

Myelin basic protein-specific T lymphocytes in multiple sclerosis and controls: precursor frequency, fine specificity, and cytotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900221-2

7 January 2021

Cell-mediated immunity to myelin-associated glycoprotein, proteolipid protein, and myelin basic protein in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900221-2

7 January 2021

MS functional composite: relation to disease phenotype and disability strata

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900221-2

7 January 2021

Predominance of the autoimmune response to myelin oligodendrocyte glycoprotein (MOG) in multiple sclerosis: reactivity to the extracellular domain of MOG is directed against three main regions

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900221-2

7 January 2021

Serum cytokine levels do not correlate with disease activity and severity assessed by brain MRI in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900221-2

7 January 2021

Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900221-2

7 January 2021

Decreased dependence of myelin basic protein-reactive T cells on CD28-mediated costimulation in multiple sclerosis patients. A marker of activated/memory T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900221-2

7 January 2021

Immunological aspects of experimental allergic encephalomyelitis and multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900221-2

7 January 2021

Immunopathogenesis of multiple sclerosis: the role of T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900221-2

7 January 2021

Review: cytokines and the pathogenesis of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900221-2

7 January 2021

Interferon beta decreases T cell activation and interferon gamma production in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900221-2

7 January 2021

Increased numbers of T cells recognizing multiple myelin basic protein epitopes in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900221-2

7 January 2021

Identification of a novel T cell epitope of human proteolipid protein (residues 40-60) recognized by proliferative and cytolytic CD4+ T cells from multiple sclerosis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900221-2

7 January 2021

Identification of a second T cell epitope of human proteolipid protein (residues 89-106) recognized by proliferative and cytolytic CD4+ T cells from multiple sclerosis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900221-2

7 January 2021

T cell response to two immunodominant proteolipid protein (PLP) peptides in multiple sclerosis patients and healthy controls

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900221-2

7 January 2021

Quantification of self-recognition in multiple sclerosis by single-cell analysis of cytokine production

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900221-2

7 January 2021

Interferon gamma production in blood lymphocytes correlates with disability score in multiple sclerosis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900221-2

7 January 2021

Myelin autoreactivity in multiple sclerosis: recognition of myelin basic protein in the context of HLA-DR2 products by T lymphocytes of multiple-sclerosis patients and healthy donors.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900221-2

7 January 2021

On the immunopathology of plaque development and repair in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900221-2

7 January 2021

In vivo effects of interferon beta-1a on immunosuppressive cytokines in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900221-2

7 January 2021

Brain atrophy in relapsing multiple sclerosis: relationship to relapses, EDSS, and treatment with interferon beta-1a

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900221-2

7 January 2021

Use of the Multiple Sclerosis Functional Composite to predict disability in relapsing MS.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900221-2

7 January 2021

The Multiple Sclerosis Functional Composite: a new clinical outcome measure for multiple sclerosis trials

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900221-2

7 January 2021

Peripheral autoantigen induces regulatory T cells that prevent autoimmunity

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900221-2

7 January 2021

Autoreactive T and B cells responding to myelin proteolipid protein in multiple sclerosis and controls

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900221-2

7 January 2021

Endogenous myelin basic protein inactivates the high avidity T cell repertoire

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900221-2

7 January 2021

Reactivity pattern and cytokine profile of T cells primed by myelin peptides in multiple sclerosis and healthy individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900221-2

7 January 2021

Peptide determinants of myelin proteolipid protein (PLP) in autoimmune demyelinating disease: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900221-2

7 January 2021

Diversity and plasticity of self recognition during the development of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900221-2

7 January 2021

The epitope spreading cascade during progression of experimental autoimmune encephalomyelitis and multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900221-2

7 January 2021

Pathologic role and temporal appearance of newly emerging autoepitopes in relapsing experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900221-2

7 January 2021

A predictable sequential determinant spreading cascade invariably accompanies progression of experimental autoimmune encephalomyelitis: a basis for peptide-specific therapy after onset of clinical disease

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900221-2

7 January 2021

10.1016/S0165-5728(03)00221-2

Identifiers

DOI

1 reference

4 February 2018

1 reference

4 February 2018